my diwali to diwali pick of 2021
buy@cmp of 385 for a tgt of 650-700
Disclaimer: The information provided herein is my opinion only. Under any circumstances do any statement here represent a recommendation to buy or sell, nor do i make any claims or promises for profits. You are responsible for your own action.consult with your financial adviser before taking any action
sastasundar recommanded@118 on march 11 2021 achieved first tgt of 300
near by 170% return in just 3 months( see the originl post by clicking the link http://valuestocks4u.blogspot.com/2021/03/sasta-sundar-creating-new-business.html
)
New EV Theme is beginning...........
My first pick is from ev segment is Kabra extrusion.....
wbsite baatrix (https://www.battrixx.com/)
website kabra(https://www.kolsite.com/)
Kabra is the flagship company of Kolsite group and one of the largest players in the plastic extrusion machinery known for its innovative offerings. KET specializes in delivering high performance extrusion solutions for manufacturing pipes and films.
But now company engaged in lithium ion battery segment under the brand Batrixx, and it is working fine and its sales is boosting. It is now available in micro cap company with 601 cr market cap, with a cash reserve of 238 cr and having book value of 80.from the last 5 years its opm back to double digit.The growth in EV segment will be faster in coming years. And the requirement for lithium based ion battery will be favour for kabra.
buy this stock @ correction around 170-160 level and my first tgt is 320 and final tgt is 400-500.
SASTA SUNDAR CREATING A NEW BUSINESS STYLE
CMP @126 TRY TO BUY@118-120 LEVELS.
ONLY FOR THE PATIENCE INVESTORS WHO LOOKING CATCHING @ YOUNG
INVESTING STYLE HOLD FOR LONG TERM MY TGT SHOULD BE 300-500.
ABOUT THE COMPANY:
SastaSundar is an online pharmacy and digital platform of healthcare supported by a network of physical counseling and service centers called ‘Healthbuddies’. The service verticals of SastaSundar are Pharmacy, Diagnostics, and Wellness.
BUSINESS MODEL.
SastaSundar operates in primarily the e-pharmacy space (84% of their revenues are from medicines; rest is from OTC/ FMCG products like green tea, sugar free snacks, hebal mouthwash, baby products etc). Their vision is to become a holistic healthcare network .
They aggregate demand by attracting consumers digitally – primarily mobile app - (by giving a 15% discount (cost) and by home delivering the medicines (convenience). The target segment is the chronic patients
Valuation
currently it is a loss making company , understand it is started as a startup so it will take time to be in a profitable zone, once it become profit zone the valuation will be change so you cant get it is @410 cr market cap.I strongly believes the business model will be attractive and can be spread other states and even they can be spread it is as b2b business model.
promotors having 74% holding in the company.
market cap:413 cr.
cash reserve:176 cr
book value :65
from last 6 years sales increased from 52 cr to 531 cr.
Technical parameters:
The stock is in a 4 year consolidation mood once cross 153 it can be 278-300 range..
* disclaimer : myself and my clients are holding shares in this company.
| Sree Rayalaseema Hi-strength Hypo Limited. cmp 294 A tvg group chemical company seems to be good ...can be a multi bagger buy @cmp 294 for a tgt of 600. The reason to buy : market cap only 430 cr. and having a cash reserve of 340 cr book value of 208, and trading @ pe of 8.11 while industry pe of 22 with in last 5 years sales increased from 362 cr to 785 cr. net profit from last 5 years increased from 19 cr to 58 cr borrowings reduced from last 5 years from 85 cr to 42 cr. Over the last 5 years, revenue has grown at a yearly rate of 11.1%, vs industry avg of 5.79% Over the last 5 years, market share increased from 0.88% to 1.13% Technical point of view it is 4 year consolidation with cup and handle pattern. |